Search by Drug Name or NDC
NDC 70710-1644-05 Verapamil Hydrochloride 2.5 mg/mL Details
Verapamil Hydrochloride 2.5 mg/mL
Verapamil Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is VERAPAMIL HYDROCHLORIDE.
Product Information
NDC | 70710-1644 |
---|---|
Product ID | 70710-1644_ba7a1f8b-81a4-49ad-ae2c-2cd08a4ffffd |
Associated GPIs | 34000030102005 |
GCN Sequence Number | 000563 |
GCN Sequence Number Description | verapamil HCl VIAL 2.5 MG/ML INTRAVEN |
HIC3 | A9A |
HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
GCN | 01650 |
HICL Sequence Number | 000180 |
HICL Sequence Number Description | VERAPAMIL HCL |
Brand/Generic | Generic |
Proprietary Name | Verapamil Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Verapamil Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2.5 |
Active Ingredient Units | mg/mL |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Labeler Name | Zydus Pharmaceuticals USA Inc. |
Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA214215 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1644-05 (70710164405)
NDC Package Code | 70710-1644-5 |
---|---|
Billing NDC | 70710164405 |
Package | 5 VIAL in 1 CARTON (70710-1644-5) / 4 mL in 1 VIAL (70710-1644-1) |
Marketing Start Date | 2020-10-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |